Literature DB >> 12428150

Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine.

Holger Russig1, Carol A Murphy, Joram Feldon.   

Abstract

RATIONALE: Psychomotor stimulants can induce psychotic states in humans that closely resemble those observed in patients with idiopathic schizophrenia. Attentional and sensorimotor gating impairments are observed in schizophrenic patients using the latent inhibition (LI) and prepulse inhibition (PPI) behavioral assays, respectively. Our previous studies demonstrated that after 4 days of withdrawal from a period of amphetamine (AMPH) administration, animals exhibited disrupted LI but normal PPI.
OBJECTIVE: The aim of the present study was to test PPI in AMPH-withdrawn rats under experimental conditions similar to those used to best demonstrate locomotor sensitization following AMPH withdrawal.
METHODS: We examined the effects on PPI of (1) pairing drug injections with PPI test-associated cues, (2) administration of a low-dose dopamine agonist challenge and (3) testing following longer withdrawal periods (23, 30, 60 days).
RESULTS: Although none of these conditions revealed a disruption of PPI in AMPH-withdrawn rats, we did observe that the acoustic startle response was reduced during a restricted time period following AMPH withdrawal. Similar to our previous findings, AMPH-withdrawn animals showed disrupted LI on day 16 of withdrawal and locomotor sensitization to a challenge injection of AMPH after 62 days of withdrawal.
CONCLUSION: We conclude that the effects of repeated AMPH on PPI are not modulated by the same experimental parameters known to be important for eliciting locomotor sensitization and that withdrawal from the schedule of AMPH administration used in this study models only specific cognitive dysfunctions linked to schizophrenic symptoms, since LI was disrupted but PPI was not affected.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428150     DOI: 10.1007/s00213-002-1254-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  68 in total

1.  Dextroamphetamine. Evaluation of psychomimetic properties in man.

Authors:  J D Griffith; J Cavanaugh; J Held; J A Oates
Journal:  Arch Gen Psychiatry       Date:  1972-02

2.  Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Authors:  I Baruch; D R Hemsley; J A Gray
Journal:  J Nerv Ment Dis       Date:  1988-10       Impact factor: 2.254

3.  Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.

Authors:  Holger Russig; Carol A Murphy; Joram Feldon
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

4.  Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window.

Authors:  T L Sills
Journal:  Brain Res Bull       Date:  1999-03-01       Impact factor: 4.077

5.  Sensitization to the behavioral effects of cocaine: modification by Pavlovian conditioning.

Authors:  R E Hinson; C X Poulos
Journal:  Pharmacol Biochem Behav       Date:  1981-10       Impact factor: 3.533

6.  Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.

Authors:  D Lin; G F Koob; A Markou
Journal:  Psychopharmacology (Berl)       Date:  1999-08       Impact factor: 4.530

Review 7.  Cocaine addiction: psychology and neurophysiology.

Authors:  F H Gawin
Journal:  Science       Date:  1991-03-29       Impact factor: 47.728

Review 8.  Dopaminergic mechanisms in idiopathic and drug-induced psychoses.

Authors:  J A Lieberman; B J Kinon; A D Loebel
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

9.  A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.

Authors:  R Y Peng; R S Mansbach; D L Braff; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1990-06       Impact factor: 7.853

10.  Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

Authors:  N S Gray; L S Pilowsky; J A Gray; R W Kerwin
Journal:  Schizophr Res       Date:  1995-09       Impact factor: 4.939

View more
  11 in total

1.  Psychostimulant-induced plasticity of intrinsic neuronal excitability in ventral subiculum.

Authors:  Donald C Cooper; Shannon J Moore; Nathan P Staff; Nelson Spruston
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

2.  Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition.

Authors:  D Peleg-Raibstein; E Sydekum; H Russig; J Feldon
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

3.  Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.

Authors:  Ming Li; Tao Sun; Alexa Mead
Journal:  J Neural Transm (Vienna)       Date:  2011-10-11       Impact factor: 3.575

4.  Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.

Authors:  Ming Li; Wei He; Alexa Mead
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

5.  Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Authors:  Brook L Henry; Mark A Geyer; Mahalah R Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

6.  Transient disruption of attentional performance following escalating amphetamine administration in rats.

Authors:  Robyn L Kondrad; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

7.  Traumatic stress in rats induces noradrenergic-dependent long-term behavioral sensitization: role of individual differences and similarities with dependence on drugs of abuse.

Authors:  Daniel Toledano; Jean-Pol Tassin; Pascale Gisquet-Verrier
Journal:  Psychopharmacology (Berl)       Date:  2013-06-29       Impact factor: 4.530

8.  Withdrawal from continuous amphetamine administration abolishes latent inhibition but leaves prepulse inhibition intact.

Authors:  Daria Peleg-Raibstein; Esther Sydekum; Holger Russig; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2006-02-10       Impact factor: 4.530

Review 9.  Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2007-06-29       Impact factor: 3.996

Review 10.  Drug Abuse and Psychosis: New Insights into Drug-induced Psychosis.

Authors:  Suji Ham; Tae Kyoo Kim; Sooyoung Chung; Heh-In Im
Journal:  Exp Neurobiol       Date:  2017-02-07       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.